PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33834359-6	2021	Moreover, we confirm of therapeutic effects of GB1107, a cell-penetrating galectin-3 specific inhibitor, using orthotopic gastric cancer-bearing mice RESULTS: Increased levels of galectin-3 and STAT3 phosphorylation were detected in the stomach tissues of WNT1-overexpressing mouse models.	GB1107	47-53	lectin, galactose binding, soluble 3	Mus musculus	74-84	
33834359-6	2021	Moreover, we confirm of therapeutic effects of GB1107, a cell-penetrating galectin-3 specific inhibitor, using orthotopic gastric cancer-bearing mice RESULTS: Increased levels of galectin-3 and STAT3 phosphorylation were detected in the stomach tissues of WNT1-overexpressing mouse models.	GB1107	47-53	lectin, galactose binding, soluble 3	Mus musculus	179-189	
33834359-10	2021	GB1107, a specific membrane-penetrating inhibitor of galectin-3, significantly reduced the activation of both STAT3 and beta-catenin and inhibited tumor growth in orthotopic gastric cancer-bearing mice.	GB1107	0-6	lectin, galactose binding, soluble 3	Mus musculus	53-63	
33834359-12	2021	Therefore GB1107, a galectin-3-specific inhibitor, maybe a potent agent with anti-gastric cancer activity.	GB1107	10-16	lectin, galactose binding, soluble 3	Mus musculus	20-30